Related Experiment Video
Updated: Sep 19, 2026

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide
Published on: August 4, 2023
Progress and challenges of biological reference standards for vaccine quality control and evaluation
Xuanxuan Zhang1, Yiping Wang1, Fan Gao1
1National Institutes for Food and Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Research Units of Innovative Vaccine Quality Evaluation and Standardization, Chinese Academy of Medical Sciences, Beijing, China.
Introduction:
Advances in the development, manufacture, and testing of biological products, along with the application of the 'Replacement, reduction and refinement,' have driven a paradigm shift in the establishment and application of biological reference standards (BRS) for vaccine quality control and evaluation. Traditional WHO International Standard(s) (IS), historically used for potency harmonization, now face multiple challenges stemming from vaccine diversity, platform complexity, and other factors.
Areas Covered:
This review summarizes recent updates to WHO and other regulatory guidelines on BRS, analyzes 2019-2025 BRS practices of WHO and regional/national regulatory authorities, highlights the need to develop BRS to support the advancement of novel platforms/technologies, and emphasizes harmonized coordination among WHO, regional/national BRS, and manufacturers' in-house quality control working standards.
Expert Opinion:
To ensure that the establishment of BRS could keep pace with vaccine evolution, the following are required: (1) establish rapid-response mechanisms to address emerging pathogens; (2) retain traditional BRS for vaccine quality control and evaluation to maintain traceability of measurement values; (3) develop platform and quality-control BRS for novel technologies; and (4) support manufacturers in developing a product-specific working BRS using Quality by Design (QbD) principles - traceable to phase III protective efficacy.
Related Concept Videos
Vaccine Production
Microorganisms in Medicine and Therapeutics
Vaccines
Vaccinations
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cell Lines
